IDO1分子的基本信息

©2004Nature Publishing Group©2004Nature Publishing GroupIMMUNOLOGY773R E V I E W S37. Silva, N. M. et al. Expression of indoleamine 2,3-dioxygenase, tryptophan degradation, and kynurenine formation during in vivo infection with Toxoplasma gondii :induction by endogenous γinterferon and requirement of interferon regulatory factor 1. Infect. Immun. 70, 859–868(2002).38. Babcock, T . A. & Carlin, J. M. Transcriptional activationof indoleamine dioxygenase by interleukin 1 and tumor necrosis factor αin interferon-treated epithelial cells.Cytokine 12, 588–594 (2000).39. Robinson, C. M., Shirey, K. A. & Carlin, J. M. Synergistictranscriptional activation of indoleamine dioxygenase by IFN-γand tumor necrosis factor-α. J. Interferon Cytokine Res.23, 413–421 (2003).40. Fujigaki, S. et al. Lipopolysaccharide induction ofindoleamine 2,3-dioxygenase is mediated dominantly by an IFN-γ-independent mechanism. Eur. J. Immunol. 31, 2313–2318 (2001).41. Yuan, W., Collado-Hidalgo, A., Yufit, T ., T aylor, M. & Varga, J.Modulation of cellular tryptophan metabolism in human fibroblasts by transforming growth factor-β: selectiveinhibition of indoleamine 2,3-dioxygenase and tryptophanyl-tRNA synthetase gene expression. J. Cell. Physiol.177,174–186 (1998).42. MacKenzie, C. R., Gonzalez, R. G., Kniep, E., Roch, S. &Daubener, W. Cytokine mediated regulation of interferon-γ-induced IDO activation. Adv. Exp. Med. Biol.467, 533–539(1999).43. Fallarino, F . et al. Modulation of tryptophan catabolism byregulatory T cells. Nature Immunol. 4, 1206–1212 (2003).This report shows that T cells expressing CTLA4induce IDO expression by DCs.44. Mellor, A. L. et al. Cutting edge: induced indoleamine 2,3dioxygenase expression in dendritic cell subsets suppresses T cell clonal expansion. J. Immunol. 171, 1652–1655 (2003).This paper shows that specific DC subsets in mouse spleens mediate dominant IDO-dependent T -cell suppression in vivo following ligation of CD80/CD86.45. Munn, D. H., Sharma, M. D. & Mellor, A. L. Ligation ofB7-1/B7-2 by human CD4+T cells triggers indoleamine 2,3-dioxygenase activity in dendritic cells. J. Immunol. 172, 4100–4110 (2004).46. Mellor, A. L. et al. Specific subsets of murine dendriticcells acquire potent T cell regulatory functions followingCTLA4-mediated induction of indoleamine 2,3 dioxygenase.Int. Immunol. (doi:10.93/intimm/dxh140).In this report, the T -cell-regulatory functions of certain cloned CD4+CD25+T cells are shown to depend on their ability to induce functional IDO expression by specific DC subsets from mouse spleens through CD80/CD86 ligation.47. Finger, E. B. & Bluestone, J. A. When ligand becomesreceptor — tolerance via B7 signaling on DCs. Nature Immunol. 3, 1056–1057 (2002).48. Kudo, Y., Boyd, C. A., Sargent, I. L. & Redman, C. W.Tryptophan degradation by human placental indoleamine 2,3-dioxygenase regulates lymphocyte proliferation. J. Physiol. 535, 207–215 (2001).49. Kudo, Y. & Boyd, C. A. Human placental indoleamine2,3-dioxygenase: cellular localization and characterization of an enzyme preventing fetal rejection. Biochim. Biophys.Acta 1500, 119–124 (2000).50. Kudo, Y. et al. Indoleamine 2,3-dioxygenase: distributionand function in the developing human placenta. J. Reprod.Immunol. 61, 87–98 (2004).51. Honig, A. et al. Indoleamine 2,3-dioxygenase (IDO)expression in invasive extravillous trophoblast supports role of the enzyme for materno–fetal tolerance. J. Reprod.Immunol. 61, 79–86 (2004).52. Baban, B. et al. Indoleamine 2,3-dioxygenase expressionis restricted to fetal trophoblast giant cells during murine gestation and is maternal genome specific. J. Reprod.Immunol. 61, 67–77 (2004).53. Mackler, A. M., Barber, E. M., T akikawa, O. & Pollard, J. W.Indoleamine 2,3-dioxygenase is regulated by IFN-γin the mouse placenta during Listeria monocytogenes infection. J. Immunol. 170, 823–830 (2003).54. T akikawa, O., Yoshida, R., Kido, R. & Hayaishi, O.Tryptophan degradation in mice initiated by indoleamine 2,3-dioxygenase. J. Biol. Chem. 261, 3648–3653 (1986).55. Yoshida, R. et al. Regulation of indoleamine 2,3-dioxygenase activity in the small intestine and the epididymisof mice. Arch. Biochem. Biophys.203, 343–351 (1980).56. Yoshida, R., Urade, Y., Nakata, K., Watanabe, Y. &Hayashi, O. Specific induction of indoleamine 2,3-dioxygenase by bacterial lipopolysaccharide in the mouse lung. Arch. Biochem. Biophys.212, 629–637 (1981).57. Fallarino, F . et al. Functional expression of indoleamine2,3-dioxygenase by murine CD8α+dendritic cells. Int. Immunol. 14, 65–68 (2002).58. Thomas, S. R. et al. Antioxidants inhibit indoleamine2,3-dioxygenase in IFN-γ-activated human macrophages:posttranslational regulation by pyrrolidine dithiocarbamate.J. Immunol. 166, 6332–6340 (2001).59. Aitken, J. B. et al. Determination of the nature of the hemeenvironment in nitrosyl indoleamine 2,3-dioxygenase using multiple-scattering analyses of X-ray absorption fine structure. Biochemistry 43, 4892–4898 (2004).60. Hucke, C., Mackenzie, C. R., Adjogble, K. D. Z., T akikawa,O. & Daubener, W. Nitric oxide-mediated regulation of γ-interferon-induced bacteriosis: inhibition of degradation of human indoleamine 2,3-dioxygenase. Infect. Immun. 72, 2723–2730 (2004).61. Pfefferkorn, E. R. Interferon-γblocks the growth ofToxoplasma gondii in human fibroblasts by inducing the host cells to degrade tryptophan. Proc. Natl Acad. A 81, 908–912 (1984).62. Carlin, J. M., Borden, E. C., Sondel, P . M. & Byrne, G. I.Interferon-induced indoleamine 2,3-dioxygenase activity in human mononuclear phagocytes. J. Leukoc. Biol. 45, 29–34 (1989).63. Gupta, S. L. et al. Antiparasitic and antiproliferative effects ofindoleamine 2,3-dioxygenase enzyme expression in human fibroblasts. Infect. Immun. 62, 2277–2284 (1994).64. MacKenzie, C. R., Hadding, U. & Daubener, W.Interferon-γ-induced activation of indoleamine 2,3-dioxygenase in cord blood monocyte-derived macrophages inhibits the growth of group Bstreptococci. J. Infect. Dis. 178, 875–878 (1998).65. Hayashi, T . et al. Enhancement of innate immunity againstMycobacterium avium infection by immunostimulatory DNA is mediated by indoleamine 2,3-dioxygenase. Infect. Immun.69, 6156–6164 (2001).66. Bodaghi, B. et al. Role of IFN-γ-induced indoleamine 2,3dioxygenase and inducible nitric oxide synthase in the replication of human cytomegalovirus in retinal pigment epithelial cells. J. Immunol. 162, 957–964 (1999).67. Adams, O. et al. Role of indoleamine-2,3-dioxygenasein α/βand γ-interferon-mediated antiviral effects against herpes simplex virus infections. J. Virol. 78, 2632–2636(2004).68. Fujigaki, S. et al. L-tryptophan-L-kynurenine pathwaymetabolism accelerated by Toxoplasma gondii infection is abolished in γ-interferon-gene-deficient mice: cross-regulation between inducible nitric oxide synthase andindoleamine-2,3-dioxygenase. Infect. Immun . 70, 779–786(2002).69. Rottenberg, M. E. et al. Regulation and role of IFN-γin theinnate resistance to infection with Chlamydia pneumoniae .J. Immunol. 164, 4812–4818 (2000).70. Widner, B., Weiss, G. & Fuchs, D. Tryptophan degradationto control T -cell responsiveness. Immunol. Today 21, 250(2000).71. Rogers, K. A. et al. T ype 1 and type 2 responses toLeishmania major . FEMS Microbiol. Lett.209, 1–7 (2002).72. Cady, S. G. & Sono, M. 1-methyl-DL-tryptophan,β-(3-benzofuranyl)-DL-alanine (the oxygen analog of tryptophan), and β-[3-benzo(b)thienyl]-DL-alanine (the sulfur analog of tryptophan) are competitive inhibitors for indoleamine 2,3-dioxygenase. Arch. Biochem. Biophys.291, 326–333 (1991).73. Mellor, A. L. et al. Prevention of T cell-driven complementactivation and inflammation by tryptophan catabolism during pregnancy. Nature Immunol. 2, 64–68 (2001).74. Alexander, A. M. et al. Indoleamine 2,3-dioxygenaseexpression in transplanted NOD islets prolongs graft survival after adoptive transfer of diabetogenic splenocytes.Diabetes 51, 356–365 (2002).75. Munn, D. H. et al. Potential regulatory function of humandendritic cells expressing indoleamine 2,3-dioxygenase.Science 297, 1867–1870 (2002).76. Summers, K. L., Hock, B. D., McKenzie, J. L. & Hart, D. N.Phenotypic characterization of five dendritic cell subsets in human tonsils. Am. J. Pathol. 159, 285–295 (2001).77. Rissoan, M. C. et al. Subtractive hybridization reveals theexpression of immunoglobulin-like transcript 7, Eph-B1,granzyme B, and 3 novel transcripts in human plasmacytoid dendritic cells. Blood 100, 3295–3303 (2002).78. G rohmann, U. et al. IFN-γinhibits presentation of atumor/self peptide by CD8α–dendritic cells via potentiation of the CD8α+subset. J. Immunol. 165, 1357–1363 (2000).This report identifies IDO as a mechanism used by mouse regulatory DCs.79. G rohmann, U. et al. CD40 ligation ablates the tolerogenicpotential of lymphoid dendritic cells. J. Immunol. 166,277–283 (2001).80. G rohmann, U. et al. IL-6 inhibits the tolerogenic functionof CD8α+dendritic cells expressing indoleamine 2,3-dioxygenase. J. Immunol. 167, 708–714 (2001).81. G rohmann, U. et al. Functional plasticity of dendriticcell subsets as mediated by CD40 versus B7 activation. J. Immunol. 171, 2581–2587 (2003).This report shows that IDO-mediated suppression can be upregulated or downregulated by signals from the immune system. 82. O’Keeffe, M. et al. Mouse plasmacytoid cells: long-livedcells, heterogeneous in surface phenotype and function,that differentiate into CD8+dendritic cells only after microbial stimulus. J. Exp. Med. 196, 1307–1319 (2002).83. Martin, P . et al. Characterization of a new subpopulation ofmouse CD8α+B220+dendritic cells endowed with type 1interferon production capacity and tolerogenic potential.Blood 100, 383–390 (2002).84. Aluvihare, V . R., Kallikourdis, M. & Betz, A. G. RegulatoryT cells mediate maternal tolerance to the fetus. Nature Immunol . 5, 266–271 (2004).85. Barcelo-Batllori, S. et al. Proteomic analysis of cytokineinduced proteins in human intestinal epithelial cells:implications for inflammatory bowel diseases. Proteomics 2, 551–560 (2002).86. Varga, J., Yufit, T . & Brown, R. R. Inhibition of collagenaseand stromelysin gene expression by interferon-γin human dermal fibroblasts is mediated in part via induction oftryptophan degradation. J. Clin. Invest. 96, 475–481 (1995).87. Meisel, R. et al. Human bone marrow stromal cells inhibitallogeneic T -cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation. Blood 103, 4619–4621(2004).88. von Bubnoff, D. et al. Fc εRI induces the tryptophandegradation pathway involved in regulating T cell responses.J. Immunol. 169, 1810–1816 (2002).89. Lee, . K. et al. Tryptophan deprivation sensitizes activatedT cells to apoptosis prior to cell division. Immunology 107,1–9 (2002).90. Fallarino, F . et al. T cell apoptosis by tryptophan catabolism.Cell Death Differ.9, 1069–1077 (2002).This report indicates that certain T cells are sensitive to the toxic effects of tryptophan metabolites that can be produced by cells expressing IDO.91. Frumento, . et al. Tryptophan-derived catabolites areresponsible for inhibition of T and natural killer cell proliferation induced by indoleamine 2,3-dioxygenase. J. Exp. Med. 196,459–468 (2002).92. T erness, P . et al. Inhibition of allogeneic T cell proliferationby indoleamine 2,3-dioxygenase-expressing dendritic cells:mediation of suppression by tryptophan metabolites. J. Exp.Med. 196, 447–457 (2002).93. Seman, M. et al. NAD-induced T cell death: ADP-ribosylation of cell surface proteins by ART2 activatesthe cytolytic P2X7 purinoceptor. Immunity 19, 571–582(2003).94. Moffett, J. R. & Namboodiri, M. A. Tryptophan andthe immune response. Immunol. Cell Biol. 81, 247–265(2003).95. Zhang, P . et al. The GCN2 eIF2αkinase is required foradaptation to amino acid deprivation in mice. Mol. Cell. Biol.22, 6681–6688 (2002).96. Harding, H. P . et al. Regulated translation initiation controlsstress-induced gene expression in mammalian cells. Mol.Cell 6, 1099–1108 (2000).97. Rohde, J., Heitman, J. & Cardenas, M. E. The TOR kinaseslink nutrient sensing to cell growth. J. Biol. Chem. 276,9583–9586 (2001).98. G ao, X. et al. T sc tumour suppressor proteins antagonizeamino-acid-TOR signalling. Nature Cell Biol. 4, 699–704(2002).99. Marshall, B., Keskin, D. B. & Mellor, A. L. Regulation ofprostaglandin synthesis and cell adhesion by a tryptophan catabolizing enzyme. BMC Biochem.2, 5 (2001).100. van Wissen, M., Snoek, M., Smids, B., Jansen, H. M. &Lutter, R. IFN-γamplifies IL-6 and IL-8 responses by airway epithelial-like cells via indoleamine 2,3-dioxygenase. J. Immunol. 169, 7039–7044 (2002).101. Li, Y., Tredget, E. E. & Ghahary, A. Cell surface expressionof MHC class I antigen is suppressed in indoleamine 2,3-dioxygenase genetically modified keratinocytes: implications in allogeneic skin substitute engraftment. Hum. Immunol.65, 114–123 (2004).102. Waldmann, H. & Cobbold, S. Exploiting tolerance processesin transplantation. Science 305, 209–212 (2004).103. Munn, D. H. & Mellor, A. L. Macrophages and the regulationof self-reactive T cells. Curr. Pharm. Des. 9, 257–264 (2003).104. Parekh, V . V . et al. B cells activated by lipopolysaccharide,but not by anti-Ig and anti-CD40 antibody, induce anergy in CD8+T cells: role of TGF-β1. J. Immunol. 170, 5897–5911(2003).105. Fillatreau, S., Sweenie, C. H., McGeachy, M. J., Gray, D. &Anderton, S. M. B cells regulate autoimmunity by provision of IL-10. Nature Immunol. 3, 944–950 (2002).©2004Nature Publishing Group。